BWVI — Psycheceutical Bioscience Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Psycheceutical Bioscience, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2009 December 31st	2010 December 31st	2011 December 31st	2021 December 31st	2022 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	PROSPECTUS	PROSPECTUS
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-0.966	0.026	-0.322	-1.41	-17
Depreciation
Amortisation
Non-Cash Items	0.304	-0.15	0.067	0.53	13.3
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	0.485	0.146	0.12	0.014	0.186
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities	0.085	0.247	0.007	-0.87	-3.46
Capital Expenditures	-0.051	-0.018	0	—	—
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	0	0.135	0	0	0.55
Sale of Business
Other Investing Cash Flow
Cash from Investing Activities	-0.051	0.117	0	0	0.55
Financing Cash Flow Items	0.096	-0.414	0.659	0.001	—
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	0.096	-0.541	0.659	1.2	4.58
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	0.133	-0.169	0.657	0.326	1.67